Published in Nat Biotechnol on January 01, 2015
Predicting disease progression in amyotrophic lateral sclerosis. Ann Clin Transl Neurol (2016) 0.75
Urinary p75(ECD): A prognostic, disease progression, and pharmacodynamic biomarker in ALS. Neurology (2017) 0.75
Erratum: Modeling the course of amyotrophic lateral sclerosis. Nat Biotechnol (2015) 0.75
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat Biotechnol (2014) 2.99
The PRO-ACT database: design, initial analyses, and predictive features. Neurology (2014) 1.26
New strategies in HER2-overexpressing breast cancer: many combinations of targeted drugs available. Clin Cancer Res (2011) 1.26
Scrutinizing enrollment in ALS clinical trials: room for improvement? Amyotroph Lateral Scler (2008) 1.00
New drugs for ALS: how do we get there? Exp Neurol (2011) 0.87